Form 8-K Amphastar Pharmaceutical For: Jul 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/29/2026
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- HF Sinclair plans to spin off lubricants unit, close Canadian refinery
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- S&P 500 ends higher as investors await tech earnings
- Crude Inventory Fell 7.2 Million Barrels Last Week - EIA
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
- After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK
FDA issues warning letter to Amphastar Pharma subsidiary over manufacturing
July 8, 2026 6:04 AM EDTAmphastar Pharmaceuticals (NASDAQ: AMPH) disclosed that its subsidiary, International Medication Systems, Limited (IMS), received a warning letter from the U.S. Food and Drug Administration on July 2, 2026, related to its drug manufacturing facility in South El Monte, California.
The warning letter follows an FDA inspection of the facility conducted in December 2025,... More
